Aug 032018
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – Cue Biopharma, Inc., (NASDAQ:CUE) a next-generation immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat cancer, autoimmune and chronic infectious diseases, announced today the addition of Frank Morich, M.D., Ph.D., to the Company's Board of Directors.… => Read full post

Cue Biopharma adds Dr Frank Morich to its Board of Directors

From:: Cue Biopharma adds Dr Frank Morich to its Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: